| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Dec 8, 2025 | Annovis Bio, Inc. | Director | Buy | 82.5 | +45,000 | 1.63% | ✗ | $193.8K |
| Nov 24, 2025 | Nov 25, 2025 | Annovis Bio, Inc. | Director | Buy | 82.5 | +39,200 | 1.44% | ✗ | $159.9K |
| Nov 24, 2025 | Nov 25, 2025 | Annovis Bio, Inc. | Director | Buy | 82.5 | +39,200 | 1.45% | ✗ | $159.9K |
| Nov 21, 2025 | Nov 21, 2025 | Annovis Bio, Inc. | Director | Buy | 72.5 | +20,000 | 0.74% | ✗ | $69.9K |
| Nov 14, 2025 | Nov 18, 2025 | Annovis Bio, Inc. | Director | Buy | 68.8 | +15,000 | 0.56% | ✗ | $31.7K |
| Oct 28, 2025 | Nov 12, 2025 | Annovis Bio, Inc. | Director | Buy | 100.0 | +975,610 | 57.28% | ✗ | $2M |
| Jan 4, 2022 | Jan 5, 2022 | Annovis Bio, Inc. | Director | Sell | 40.0 | -6,748 | -0.24% | ✗ | $133.5K |
| Aug 27, 2020 | Aug 31, 2020 | Traws Pharma, Inc. | Director | Sell | 22.5 | -184,368 | -89.13% | ✗ | $50.1K |
| Jan 31, 2020 | Feb 5, 2020 | Annovis Bio, Inc. | Director | Buy | 95.0 | +33,333 | 233.33% | ✗ | $200K |
| Aug 27, 2018 | Aug 29, 2018 | Traws Pharma, Inc. | Director | Sell | 26.3 | -99,999 | -1.71% | ✗ | $45.2K |
| Feb 20, 2014 | Feb 24, 2014 | Traws Pharma, Inc. | Director | Buy | 92.5 | +143,480 | 3.22% | ✓ | $1.2M |
| Jan 24, 2014 | Jan 27, 2014 | Traws Pharma, Inc. | Director | Buy | 85.0 | +57,295 | 1.30% | ✓ | $682.7K |
| Nov 22, 2013 | Nov 25, 2013 | Traws Pharma, Inc. | Director | Buy | 60.0 | +5,000 | 0.11% | ✗ | $71.9K |
| Nov 18, 2013 | Nov 20, 2013 | Traws Pharma, Inc. | Director | Buy | 60.0 | +5,000 | 0.11% | ✗ | $59.4K |
| Nov 15, 2013 | Nov 18, 2013 | Traws Pharma, Inc. | Director | Buy | 65.0 | +19,700 | 0.45% | ✗ | $236.3K |
| Jul 30, 2013 | Aug 1, 2013 | Traws Pharma, Inc. | Director | Buy | 100.0 | +1,000,000 | 29.65% | ✗ | $15M |